Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05069519 · ClinicalTrials.gov registry record · NA

Implementing Personalized Exercise Prescriptions Through Mobile Health in the Elderly Cancer Survivors

A NA study of Cancer, sponsored by University of Minnesota.

Completed
Registry status
NA
Development phase
126
Enrollment target
1
Study location

NCT05069519: Completed NA study of Cancer, sponsored by University of Minnesota.

NCT05069519 is a NA study of Cancer that has completed, run by University of Minnesota. The registered enrollment target is 126 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05069519, a NA study of Cancer, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
NA
Development phase
126 participants
Enrollment target
1
Study location

Study Summary

Cancer remains a vital public health concern in the U.S. Research evidence has shown that physical activity provides many physical and mental health benefits after cancer diagnosis and plays an important role in reducing all-cause, cancer-related death and cancer events in the elderly cancer survivors (CS). Adopting a physically active lifestyle may decrease cancer risks, improve cancer prognosis and quality of life. However, most CS did not achieve recommended 150 min/week of moderate-to- vigorous physical activity (PA \[MVPA\]). This issue is particularly pronounced for CS in low-income areas who tend to have considerably less access to PA-conducive environments compared to urban peers. To this accord, it is imperative to promote PA in elderly CS to offer appropriate supportive care. Thus, implementing innovative PA interventions with the goal of improving their self-regulatory health behaviors in CS is paramount.

Primary Outcome

Participants' 1-week daily steps will be assessed using Fitbit Charger 4. They will be instructed to wear the Fitbit on the non-dominant wrist at all times throughout the study and daily steps will be recorded. Daily steps will be measured at baseline, 3 months, and 6 months, and the difference between baseline and 6 months will be reported.

Conditions Studied

Interventions

  • BEHAVIORAL Personalized Smartwatch
  • BEHAVIORAL Facebook Health Education

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2021-11-01
Est. Completion 2022-10-30
Phase NA
University of Minnesota

966 total trials

What the finished NCT05069519 record still lists

NCT05069519 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Personalized Smartwatch is the first listed.

NCT05069519 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT05069519 about?

NCT05069519 is a clinical study titled "Implementing Personalized Exercise Prescriptions Through Mobile Health in the Elderly Cancer Survivors". Cancer remains a vital public health concern in the U.S. Research evidence has shown that physical activity provides many physical and mental health benefits after cancer diagnosis and plays an important role in reducing all-cause, cancer-related death and cancer events in the elderly cancer survivo...

What is the current status of trial NCT05069519?

This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2021-11-01. Estimated completion is 2022-10-30.

What conditions does trial NCT05069519 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT05069519?

The interventions under investigation include: Personalized Smartwatch (BEHAVIORAL), Facebook Health Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT05069519?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05069519 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05069519's enrollment target sits among peer trials

126 282nd of 615 higher than 331 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05069519, the US trial registry maintained by the National Library of Medicine. NCT05069519 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.